分组1 - Orthofix reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.12 per share, and showing an increase from $0.07 per share a year ago, representing an earnings surprise of +66.67% [1] - The company achieved revenues of $205.63 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.65% and increasing from $196.61 million year-over-year [2] - Over the last four quarters, Orthofix has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed, losing about 8% since the beginning of the year, while the S&P 500 has gained 16.5% [3] - The current consensus EPS estimate for the upcoming quarter is $0.38 on revenues of $219.16 million, and for the current fiscal year, it is $0.54 on revenues of $812.83 million [7] - The Zacks Industry Rank for Medical - Instruments is in the top 38% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]
Orthofix (OFIX) Beats Q3 Earnings and Revenue Estimates